drugset / Trial / NCT04312932
Fatty Acid Supplementation in Children With ASD (Study 2)
Phase 2
Completed
98 enrolled
Sarah Keim
National Center for Complementary and Integrative Health (NCCIH) · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The objective of the protocol is to test the impact of Omega 3-6 on pre-specified biological signatures (IL-1β, IL-2, and IFNγ) and to correlate changes in the biological signatures with changes in ASD symptoms.
Timeline
- Start
- 2021-12-01
- Primary completion
- 2023-11-28
- Completion
- 2024-04-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LCPUFA Oil Supplement | Other / unclassified | 25 mg/kg | Oral |
| Subject | LCPUFA Oil Supplement | Other / unclassified | 50 mg/kg | Oral |
| Subject | LCPUFA Oil Supplement | Other / unclassified | 75 mg/kg | Oral |